Loading jobs…
Loading jobs…
Atalanta Therapeutics — Boston, Massachusetts
Company Overview Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts. Summary The Senior Director, Clinical Development will provide medical and scientific leadership for Tango’s oncology development programs, driving clinical strategy from early-stage development through registration. Reporting to the President, Research Development, this individual will lead cross-functional clinical teams, shape development plans, oversee study execution and medical monitoring, and serve as a key partner to investigators, regulators, and senior leadership.
Responsibilities
and offers the opportunity to directly influence the advancement of innovative precision oncology therapies for patients. The Senior Director will build and maintain strong relationships with investigators, key opinion leaders (KOLs), and external partners while ensuring the successful execution of clinical studies and overall program objectives.
as required to support the advancement of Tango’s clinical programs What You Bring: MD required; board certification or board eligibility in Medical Oncology, Hematology/Oncology, or a related specialty strongly preferred 5+ years of clinical development experience within the biotechnology and/or pharmaceutical industry, including experience leading oncology development programs Demonstrated experience in the design, execution, interpretation, and reporting of oncology clinical trials involving t